【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 29
3.1.3 Basic Breast Anatomy 30
3.2 Disease Classification/Staging Systems 31
3.3 Symptoms 33
3.4 Prognosis 33
3.5 Quality of Life 34
4 Epidemiology 37
4.1 Disease Background 37
4.2 Risk Factors and Comorbidities 37
4.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk 39
4.2.2 Reproductive hormonal factors influence the risk of breast cancer 39
4.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients 41
4.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks 43
4.3 Global Trends 46
4.3.1 Incidence 46
4.3.2 Prevalence and Survival 52
4.4 Forecast Methodology 56
4.4.1 Sources Used 58
4.4.2 Sources Not Used 62
4.4.3 Forecast Assumptions and Methods 63
4.5 Epidemiological Forecast for Breast Cancer (2013-2023) – Diagnosed Incident Cases 66
4.5.1 Diagnosed Incident Cases of Breast Cancer 66
4.5.2 Diagnosed Incident Cases of Breast Cancer by Age 68
4.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status 70
4.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis 72
4.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer 73
4.6 Epidemiological Forecast for Breast Cancer (2013-2023) — Diagnosed Prevalent Cases 74
4.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer 74
4.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status 76
4.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes 77
4.7 Discussion 79
4.7.1 Epidemiological Forecast Insight 79
4.7.2 Limitations of the Analysis 81
4.7.3 Strengths of the Analysis 82
5 Disease Management 84
5.1 Diagnosis and Treatment Overview 84
5.1.1 Treatment of Early-Stage Breast Cancer (Stage 0 to Stage IB) 84
5.1.2 Treatment of Locally-Advanced and Regional Breast Cancer (Stage IB to IIIC) 86
5.1.3 Treatment Guidelines and Leading Prescribed Drugs 90
5.2 US 91
5.2.1 Diagnosis 91
5.2.2 Clinical Practice 92
5.3 France 95
5.3.1 Diagnosis 95
5.3.2 Clinical Practice 96
5.4 Germany 99
5.4.1 Diagnosis 99
5.4.2 Clinical Practice 100
5.5 Italy 103
5.5.1 Diagnosis 103
5.5.2 Clinical Practice 104
5.6 Spain 106
5.6.1 Diagnosis 106
5.6.2 Clinical Practice 107
5.7 UK 110
5.7.1 Diagnosis 110
5.7.2 Clinical Practice 111
5.8 Japan 114
5.8.1 Diagnosis 114
5.8.2 Clinical Practice 115
5.9 China 117
5.9.1 Diagnosis 117
5.9.2 Clinical Practice 119
6 Competitive Assessment 122
6.1 Overview 122
6.2 Product Profiles (Branded Therapies) 123
6.2.1 Abraxane (nab-paclitaxel) 123
6.2.2 Afinitor (everolimus) 128
6.2.3 Avastin (bevacizumab) 133
6.2.4 Doxil/Caelyx (pegylated liposomal doxorubicin) 137
6.2.5 Halaven (eribulin mesylate) 142
6.2.6 Ixempra (ixabepilone) 145
6.2.7 Xeloda (capecitabine) 148
6.3 Product Profiles (Hormonal Agents) 151
6.3.1 Tamoxifen 151
6.3.2 Faslodex (fulvestrant) 151
6.3.3 Aromatase Inhibitors 152
7 Unmet Need and Opportunity 156
7.1 Overview 156
7.1.1 Defined treatment plan for BRCA mutation-positive patients and prevention of prophylactic surgeries 158
7.1.2 Specific treatment options for TNBC patients 160
7.1.3 Prevention of brain metastasis 161
7.1.4 Neoadjuvant therapy that can downstage tumors 163
7.1.5 For HR+patients, reduced resistance to hormonal agents 164
7.1.6 Improved convenience of administration of hormonal agents 166
8 Pipeline Assessment 168
8.1 Overview 168
8.1.1 Abemaciclib (LY2835219) 169
8.1.2 Buparlisib (BKM- 120) 175
8.1.3 Javlor (vinflunine) 181
8.1.4 LEE011 185
8.1.5 NeuVax (nelipepimut-S/E75) 190
8.1.6 Niraparib (MK4827) 195
8.1.7 NKTR- 102 (etirinotecan pegol) 200
8.1.8 Lynparza (olaparib) 204
8.1.9 Palbociclib (PD-0332991) 209
8.1.10 Talazoparib (BMN 673) 215
8.1.11 Veliparib (ABT-888) 219
8.2 Promising Drugs in Clinical Development 224
8.2.1 PD-/PD-L 1 Immunotherapies 225
9 Current and Future Players 227
9.1 Overview 227
9.2 Trends in Corporate Strategy 229
9.3 Company Profiles 232
9.3.1 AstraZeneca 232
9.3.2 Bristol-Myers Squibb 233
9.3.3 Eli Lilly 235
9.3.4 Pfizer 236
9.3.5 Novartis/GlaxoSmithKline 239
10 Market Outlook 241
10.1 Global Markets 241
10.1.1 Forecast 241
10.1.2 Drivers and Barriers – Global Issues 247
10.2 US 249
10.2.1 Forecast 249
10.2.2 Key Events 252
10.2.3 Drivers and Barriers 253
10.3 France 255
10.3.1 Forecast 255
10.3.2 Key Events 258
10.3.3 Drivers and Barriers 259
10.4 Germany 260
10.4.1 Forecast 260
10.4.2 Key Events 264
10.4.3 Drivers and Barriers 265
10.5 Italy 266
10.5.1 Forecast 266
10.5.2 Key Events 270
10.5.3 Drivers and Barriers 271
10.6 Spain 272
10.6.1 Forecast 272
10.6.2 Key Events 275
10.6.3 Drivers and Barriers 276
10.7 UK 277
10.7.1 Forecast 277
10.7.2 Key Events 281
10.7.3 Drivers and Barriers 282
10.8 Japan 284
10.8.1 Forecast 284
10.8.2 Key Events 287
10.8.3 Drivers and Barriers 288
10.9 China 289
10.9.1 Forecast 289
10.9.2 Key Events 292
10.9.3 Drivers and Barriers 292
11 Appendix 294
11.1 Bibliography 294
11.2 Abbreviations 321
11.3 Methodology 329
11.4 Forecasting Methodology 329
11.4.1 Diagnosed HER2-Negative Breast Cancer Patients 329
11.4.2 Percentage of Drug-Treated Patients 330
11.4.3 Drugs Included in Each Therapeutic Class 330
11.4.4 Launch and Patent Expiry Dates 331
11.4.5 General Pricing Assumptions 332
11.4.6 Individual Drug Assumptions 334
11.4.7 Generic Erosion 342
11.4.8 Pricing of Pipeline Agents 342
11.5 Primary Research – KOLs Interviewed for This Report 353
11.6 Primary Research – High-Prescriber Survey 355
11.7 About the Authors 356
11.7.1 Analyst 356
11.7.2 Director of Oncology 356
11.7.3 Epidemiologist 357
11.7.4 Director of Epidemiology 357
11.7.5 Global Head of Healthcare 358
11.8 About GlobalData 359
11.9 Disclaimer 359
【レポート販売概要】
■ タイトル：HER2陰性乳癌治療薬の世界市場予測および分析■ 英文：PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2015年1月31日
■ 調査会社：GlobalData
■ 商品コード：GDHC92PIDR
■ 調査対象地域：グローバル
- 世界のエンタープライズ製造インテリジェンス市場動向（2012-2016）TechNavio's analysts forecast the Global Enterprise Manufacturing Intelligence market to grow at a CAGR of 10.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for enterprises to improve operational performance. The Global Enterprise Manufacturing Intelligence market has also been witnessing the demand for packaged software solutions. Howev …
- 食品用安定剤の世界市場予測（～2020）The food stabilizers market is projected to grow at a CAGR of 4.2% from 2015 to reach USD 9.10 Billion by 2020. The food stabilizers industry is driven by the growing demand for specialized and customized blends for each specific application. The food stabilizers market is further driven by the rise in demand for baked foods, dairy products, and change in consumer lifestyles, consequent to increas …
- Devon Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Devon Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Devon Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 菓子の世界市場：チョコレート、ガム、砂糖菓子About confectionery Confectioneries are regularly consumed on an everyday basis. The confectionery market can be divided into three major categories: chocolates, gums, and sugar confectioneries. Technavio's analysts forecast the global confectionery market to grow at a CAGR of 2.68% over the period 2014-2019. [Covered in this report] The report covers the current scenario and growth prospects of t …
- Sezary Syndrome：グローバル臨床試験レビューH2, 2013Sezary Syndrome Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H2, 2013" provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as …
- 光線療法装置の世界市場分析：製品別（従来の蛍光灯と小型蛍光灯; LED; 光ファイバー）、用途別（皮膚疾患治療、新生児黄疸）、セグメント予測、2014-2025The global phototherapy equipment market is expected to reach a value of USD 788.7 million by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of skin diseases has led to huge growth of phototherapy equipment market. According to healthline data, nearly 150,000 new psoriasis cases develop each year among the U.S. population. With such huge population developing psoria …
- 世界の航空宇宙分野向けロボット市場動向（2012-2016）TechNavio's analysts forecast the Global Aerospace Service Robotics market to grow at a CAGR of 24.11 percent over the period 2012-2016. One of the key factors contributing to this market growth is the development of telerobotics for space. The Global Aerospace Service Robotics market has also been witnessing an increase in the demand for unmanned aerial vehicles. However, rapid technological chan …
- 紙製パッケージの世界市場：段ボール箱、板紙、包装紙The global paper packaging market is expected to witness significant change in its competitive landscape over 2015-2025. We expect the BRIC markets to represent approximately 30% of global demand, as their economies further develop. Packaging sales in the emerging markets are expected to continue to show strong growth as increasing consumption and demand for consumer goods continue to drive the ne …
- 世界の大豆食品、大豆添加物、大豆油市場（2014-2018）About the Soy Food Market Soy food products, such as tofu and soy milk, have been consumed as traditional foods in Asia. With a rise in awareness of the health benefits of soy food, it has gained popularity worldwide, and, currently, it is among the most consumed food products. Earlier, soy food products in retail stores were restricted to tofu, soy milk, and poorly textured meat substitutes; but …
- 自動車用保護フィルムのアメリカ市場分析The U.S. automotive protection films market is estimated to reach a market size of USD 425.4 million by 2025, according to a new report by Grand View Research, Inc. The growth of the U.S. automotive industry is the major factor expected to drive market growth during the forecast period. The increasing vehicle production in the country is slated to have positive impacts on the overall product deman …
- 微生物攻法の世界市場2018-2022About Microbial Enhanced Oil Recovery Microbial enhanced oil recovery is a tertiary oil recovery process that involves the use of microorganisms and their metabolites to reduce the residual oil saturation of reservoirs primarily through wettability alteration and interfacial tension (IFT) reduction. Technavio’s analysts forecast the global microbial enhanced oil recovery market to grow at a CAGR o …
- ピリドキサミン二塩酸塩の世界市場2015Pyridoxamine Dihydrochloride (CAS 524-36-7) Market Research Report 2015 aims at providing comprehensive data on Pyridoxamine Dihydrochloride market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Pyridoxamine Dihydrochloride description, covers its application areas, manufacturing methods, patterns. It captures Pyridoxamine Dihydrochloride market trend …
- 変圧器監視ソリューションの世界市場：配電変圧器監視、電源変圧器監視About Transformer Monitoring Solutions Transformer monitoring solutions monitor and diagnose the health of a transformer. A monitoring solution helps end-users to detect and identify any failure in transformers before it becomes evident, thereby reducing the costs involved in repair. A transformer monitoring solution is an integration of sensors, data management and analysis, and software applicat …
- 赤ちゃん用製品の世界市場分析：製品別（化粧品・トイレタリー、ベビーフード、赤ちゃんの安全と利便性）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ）、セグメント予測、2014-2025The global baby product market is expected to reach USD 121.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising spending capability in matured economies of North America and Europe will augment industry growth over the next nine years. Increasing birthrate in emerging economies of Asia Pacific including India and China is anticipated to drive the demand for infant item …
- 世界の糖化ヘモグロビン検査機器市場2015The Global Glycated Hemoglobin Testing Industry Report 2015 is a professional and in-depth study on the current state of the Glycated Hemoglobin Testing industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Glycated Hemoglobin Testing market analysis is provided for the international markets including de …
